ANIMATION

HuLuc 63

Share this animation:

PDL BioPharma asked XVIVO to show how a novel humanized antibody, HuLuc 63, appears to induce anti-tumor effects by binding to a protein expressed only on the surface of myeloma cells. This initiates antibody-dependent cytotoxic activity which targets myeloma cells while leaving healthy cells intact.

Share It:
Contact XVIVO

Client


PDL BioPharma

I wanted to share with you the news I just heard that the fabulous image you prepared for us has been selected for the cover of Cell! This is wonderful testimony to your talent and ability to rapidly reduce an idea to a stunning illustration. We were particularly impressed with your responsiveness and ability to quickly make significant modifications to meet our external deadlines. Many thanks for all your help, and congratulations!

Richard P. Lifton: Chairman, Yale University Department of Genetics; Sterling Professor of Genetics, Medicine and Molecular Biophysics and Biochemistry; Investigator, Howard Hughes Medical Institute
Share this animation: